ARCHIVES

FDA, NCI, CMS Announce Biomarker Initiative; First Project To Validate FDG-PET As Predictor Of Tumor Response In Non-Hodgkin’s Lymphoma.

This article is from The Cancer Letter archive.

Vol. 32 No. 06 | February 17, 2006

Download PDF Visit The Full Archive

Related Articles

Seattle Times, The Hutch Duel Over Five-Part Series.

March 23, 2001

Rays Of Hope Candlelight Vigil Scheduled For Oct. 6.

September 8, 2000

NIH Carcinogen Guidelines Offered

April 24, 1981

Garb’s Fight Now A Personal One

March 20, 1981

Bush Appoints Niederhuber Chairman of NCAB

August 2, 2002

Pepper’s Legacy Included NCI, Other Biomedical Research

June 9, 1989